Talebi Ardeshir, Kianersi Kianoosh, Beiraghdar Mozhdeh
Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv Biomed Res. 2015 Oct 22;4:234. doi: 10.4103/2277-9175.167958. eCollection 2015.
Cancer stem cells have been isolated and characterized in all common cancers. SOX2 and OCT4 are important genes to enhance the self-renewal ability as activate stem cells and inhibit the genes that start differentiation and thus maintain the self-renewal ability of stem cells. Also, the aim of this study is "Comparison of gene expression of SOX2 and OCT4 in normal tissue, polyps, and colon adenocarcinoma using immunohistochemical staining."
This cross-sectional study conducted on 20 patients so that for each patient, a sample of healthy tissue, dysplastic polyp tissue, and colon adenocarcinoma were provided as microscopic sections and staining on each tissue was performed through immunohistochemistry method by markers OCT4 and SOX2. The collected data were interred into SPSS version 18.0, (SPSS Inc., Chicago, IL, USA) software and the level of significance were considered as <0.05.
The study sample consisted of 20 patients including 11 men (55%) and 9 women (45%) with a mean age of 55.6 ± 9.88 years. There was no association between Oct4 and colorectal cancer (CRC) patients (P > 0.05), but there was a significant correlation between Sox2 expression and CRC (P < 0.05). Patients in many aspects such as race, type of polyp, presence of lymph node, grade and intensity of Sox2 in different types of patients' tissues (P < 0.05).
Regarding our findings, the expression of Sox2 would be a liable marker for evaluating of cancer progression and could be a treatment target of CRC cells.
癌症干细胞已在所有常见癌症中被分离和鉴定。SOX2和OCT4是增强自我更新能力的重要基因,它们可激活干细胞并抑制启动分化的基因,从而维持干细胞的自我更新能力。此外,本研究的目的是“使用免疫组织化学染色比较正常组织、息肉和结肠腺癌中SOX2和OCT4的基因表达”。
本横断面研究对20例患者进行,为每位患者提供健康组织、发育异常息肉组织和结肠腺癌的样本作为显微切片,并通过免疫组织化学方法用OCT4和SOX2标记物对每个组织进行染色。收集的数据录入SPSS 18.0版(美国伊利诺伊州芝加哥SPSS公司)软件,显著性水平设定为<0.05。
研究样本包括20例患者,其中男性11例(55%),女性9例(45%),平均年龄55.6±9.88岁。Oct4与结直肠癌(CRC)患者之间无关联(P>0.05),但Sox2表达与CRC之间存在显著相关性(P<0.05)。在种族、息肉类型、淋巴结存在情况、不同类型患者组织中Sox2的分级和强度等许多方面,患者之间存在差异(P<0.05)。
根据我们的研究结果,Sox2的表达可能是评估癌症进展的可靠标志物,并且可能是CRC细胞的治疗靶点。